@article{5b5f0fc04d434b6eaeef70160b81e6a9,
title = "Phase II proof-of-concept trial of the orexin receptor antagonist filorexant (MK-6096) in patients with major depressive disorder",
keywords = "Depression, Filorexant, Mk-6096, Orexin receptor antagonist",
author = "Connor, {Kathryn M.} and Paulette Ceesay and Jill Hutzelmann and Duane Snavely and Krystal, {Andrew D.} and Trivedi, {Madhukar H.} and Michael Thase and Christopher Lines and Herring, {W. Joseph} and David Michelson",
note = "Publisher Copyright: {\textcopyright} The Author 2017.",
year = "2017",
month = aug,
day = "1",
doi = "10.1093/ijnp/pyx033",
language = "English",
volume = "20",
pages = "613--618",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
number = "8",
}